HeraMED Ltd
HeraMED Limited is an Australia-based medical data and technology company.
The business
HeraMED Limited is an Australia-based medical data and technology company. The Company is engaged in the digital transformation of maternity care by transforming the prenatal and postpartum experience with its hybrid maternity care platform. The Company offers a proprietary platform that utilizes hardware and software to reshape the doctor/patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, and big data. The HeraBEAT medical device is used by pregnant women in Europe, the United States, Israel and Australia. The Company’s proprietary offering, HeraCARE, is engineered to offer a fully integrated maternal health ecosystem designed to deliver care to ensure expectant mothers are engaged, informed and well-supported, allowing healthcare professionals to provide quality care and enable early detection and prevention of potential risks.
Small Caps Research
No research on HeraMED Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise HMD based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
HeraMED Clears First Lee Health Digital Obstetrics Pilot Phase
HeraMED Phase 1 Lee Health digital obstetrics pilot validates HeraCARE; 44 patients, 92% adopt digital path; Phase 2 decision soon.
Market wrap: rally continues despite disappointing mining stocks
A broad-based rise in banking, healthcare and technology stocks helped to overcome disappointing share price falls by miners dragged down by lower commodity prices. By the market close on Friday the ASX 200 finished up 0.3% or 26.6 points higher at 7796 points, representing a 0.9% gain for the week after the Reserve Bank held […]
HeraMED’s digital maternity care platform HeraCARE logs record user growth
Digital maternity care specialist HeraMED (ASX: HMD) continues to attract strong support for its unique HeraCARE platform. The end-to-end digital maternity monitoring and management platform has reached a record number of accumulated users, with further strong growth forecast. According to HeraMED, the number registered on the HeraCARE platform as of 15 June 2024 reached 3,533—representing […]
HeraMED teams up with eCare21 to deliver smart solution for in-home maternity care to US patients
Maternity-focused technology start-up HeraMED (ASX: HMD) has signed an agreement with US virtual care provider eCare21 to integrate its smart pregnancy monitoring solutions into eCare21’s software-as-a-service (SaaS) platform. Under the agreement, the digital HeraCARE platform – including the clinically-validated, in-home foetal and maternal heart rate monitor HeraBEAT – will be fully integrated into eCare21’s platform […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.